Skip to main content
Andreas Klein, MD, Hematology, Boston, MA

Andreas K Klein MD

Hematologic Oncology


Wellforce

Join to View Full Profile
  • 750 Washington StBoston, MA 02111

  • Phone+1 617-636-5000

  • Fax+1 617-636-6204

Dr. Klein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 1998 - 2001
  • Tufts Medical Center
    Tufts Medical CenterResidency, Internal Medicine, 1995 - 1998
  • Yale School of Medicine
    Yale School of MedicineClass of 1995

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2025
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • ME State Medical License
    ME State Medical License 2020 - 2021
  • NC State Medical License
    NC State Medical License 1998 - 2001
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014, 2016-2017, 2019-2022
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clinicopathologic Characteristics of Secondary Squamous Cell Carcinoma of Head and Neck in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation for Hematolo...  
    Kenneth B Miller, Kellie A Sprague, Chakra P Chaulagain, Esha Kaul, Andreas K Klein, Janet Cowan, Nature

Abstracts/Posters

  • A Phase I/II Trial of Brentuximab Vedotin (BV) Plus Rituximab (R) As Frontline Therapy for Patients with Immunosuppression-Associated CD30+ and/or EBV+ Lymphomas
    Andreas Klein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
    Andreas Klein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Supervised Machine Learning Algorithms Using Patient Related Factors to Predict in-Hospital Mortality Following Acute Myeloid Leukemia Therapy
    Andreas Klein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Center for Health Literacy Research + Practice
    Center for Health Literacy Research + PracticeAugust 23rd, 2024
  • Development and Clinical Application of CD19xCD3 and CD20xCD3 Bispecific Antibodies
    Development and Clinical Application of CD19xCD3 and CD20xCD3 Bispecific AntibodiesJanuary 17th, 2022
  • Old Idea, New Desperation: Can Plasma from Recovered Patients Help Those Now Battling COVID-19?
    Old Idea, New Desperation: Can Plasma from Recovered Patients Help Those Now Battling COVID-19?May 22nd, 2020
  • Join now to see all

Committees

  • Chair, Tufts Health Sciences Institutional Review Board 2010 - Present

Professional Memberships

Other Languages

  • Spanish, Chinese (Mandarin), Vietnamese, Portuguese, Thai, Chinese (Cantonese), Creole, Tamil, Croatian

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: